Bannari Amman Sugars
Bannari Amman Sugars
Consumer GoodsKey Fundamentals
MicrocapSugarConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
3- The company has delivered a poor sales growth of 4.17% over past five years.
- Company has a low return on equity of 7.51% over last 3 years.
- Dividend payout has been low at 12.0% of profits over last 3 years
Growth Rate
AI Analysis — Bull vs Bear
Bannari Amman Sugars Ltd is a nearly debt-free sugar company with a market cap of Rs 4,358 crore, trading at a PE of 30x. The company shows inconsistent sales growth (5-year CAGR of 4%) but has delivered strong recent profit growth (TTM 41%), while maintaining a modest ROE of around 8%.
- Company is almost debt-free, having significantly reduced its leverage, which strengthens the balance sheet and lowers financial risk
- TTM compounded profit growth of 41% indicates a strong earnings recovery in the most recent period
- 5-year compounded profit CAGR of 11% demonstrates consistent medium-term earnings growth
- 10-year compounded profit CAGR of 17% shows the company has delivered solid long-term earnings compounding
- 5-year stock price CAGR of 15% indicates meaningful wealth creation for medium-term shareholders
- Price-to-book ratio of 2.32x is reasonable for a debt-free FMCG-adjacent company, suggesting the stock is not excessively priced on asset basis
- TTM sales growth of 7% shows a recovery from the 3-year negative sales CAGR of -9%, suggesting a revenue turnaround is underway
- 5-year compounded sales growth of only 4.17% reflects poor top-line expansion, raising concerns about demand or pricing power
- 3-year compounded sales CAGR of -9% indicates revenue actually declined over the recent 3-year window
- Return on equity of 7.77% over last 3 years (and 8% across multiple periods) is low, suggesting the company does not generate strong returns on shareholder capital
- PE ratio of 30x is elevated relative to the modest 8% ROE and 4% 5-year sales growth, implying the stock may be pricing in growth that has not materialized consistently
- Dividend payout of only 12% of profits over the last 3 years with a yield of 0.36% offers minimal income to shareholders
- 1-year stock price CAGR of -11% indicates recent underperformance and negative momentum
- 10-year sales CAGR of just 3% demonstrates structurally slow revenue growth over a full business cycle
- 3-year compounded profit CAGR of only 1% suggests that outside the recent TTM spike, earnings growth has been stagnant
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Rs 12.72 cr recovery notice Jul 2
District Collector Erode initiated recovery of Rs 12.72 crore under the Revenue Recovery Act for tax dues. The company plans to challenge the notice legally.
- Cybersecurity incident resolved quickly Jun 29
A cybersecurity incident occurred on June 27 at the Tamil Nadu distillery unit but was resolved promptly with no operational disruption or impact on business continuity.
TL;DR: Bannari Amman Sugars faces a Rs 12.72 crore tax recovery notice from Erode district authorities, which adds a near-term financial and legal overhang. On the operational front, a cybersecurity incident at its distillery unit was contained without disruption, indicating adequate incident response. The risk profile has slightly deteriorated due to the revenue recovery proceedings, though the company's intent to legally challenge may limit eventual impact.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 431 | 600 | 768 | 421 | 404 | 474 | 421 | 494 | 419 | 572 | 644 | 282 | 172 |
| Expenses | 387 | 508 | 649 | 370 | 375 | 406 | 360 | 441 | 382 | 497 | 561 | 279 | 178 |
| Operating Profit | 44 | 92 | 119 | 51 | 29 | 67 | 61 | 53 | 37 | 75 | 83 | 4 | -5 |
| OPM % | 10% | 15% | 16% | 12% | 7% | 14% | 15% | 11% | 9% | 13% | 13% | 1.3% | -3% |
| Other Income | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 21 | 4 | 7 | 5 | 27 | 6 |
| Interest | 10 | 7 | 7 | 8 | 6 | 2 | 4 | 3 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 14 | 14 | 14 | 15 | 14 | 14 | 14 | 16 | 15 | 15 | 15 | 15 | 15 |
| PBT | 20 | 73 | 100 | 31 | 10 | 53 | 45 | 55 | 24 | 66 | 73 | 15 | -14 |
| Tax % | 33% | 33% | 32% | 30% | 35% | 35% | 35% | 36% | 37% | 35% | 33% | -179% | -25% |
| Net Profit | 14 | 49 | 68 | 22 | 6 | 34 | 29 | 35 | 15 | 43 | 48 | 42 | -11 |
| EPS in Rs | 10.84 | 38.92 | 54.28 | 17.41 | 5.13 | 27.33 | 22.98 | 28.04 | 12.16 | 34.05 | 38.59 | 33.16 | -8.71 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 930 | 1,456 | 1,752 | 1,481 | 1,125 | 1,609 | 1,563 | 1,998 | 2,526 | 2,220 | 1,793 | 1,917 | 1,670 |
| Expenses | 802 | 1,251 | 1,404 | 1,270 | 943 | 1,378 | 1,352 | 1,780 | 2,221 | 1,914 | 1,583 | 1,719 | 1,514 |
| Operating Profit | 128 | 204 | 348 | 211 | 182 | 231 | 211 | 218 | 304 | 306 | 210 | 198 | 156 |
| OPM % | 14% | 14% | 20% | 14% | 16% | 14% | 13% | 11% | 12% | 14% | 12% | 10% | 9% |
| Other Income | 16 | 3 | 6 | 5 | 8 | 4 | 9 | 3 | 39 | 7 | 26 | 43 | 45 |
| Interest | 93 | 116 | 97 | 34 | 30 | 44 | 39 | 32 | 49 | 32 | 16 | 2 | 1 |
| Depreciation | 51 | 62 | 69 | 70 | 67 | 65 | 66 | 68 | 74 | 58 | 59 | 61 | 61 |
| PBT | 0 | 30 | 187 | 112 | 93 | 126 | 115 | 122 | 220 | 224 | 162 | 177 | 139 |
| Tax % | -209% | -7% | 22% | 22% | 18% | 24% | 20% | 34% | 35% | 32% | 35% | 17% | — |
| Net Profit | 1 | 32 | 145 | 87 | 76 | 96 | 92 | 80 | 143 | 152 | 105 | 148 | 122 |
| EPS in Rs | 0.9 | 27.73 | 116 | 69.59 | 60.56 | 76.27 | 73.48 | 63.78 | 114 | 121 | 83.47 | 118 | 97.09 |
| Div. Payout % | 278% | 27% | 11% | 14% | 17% | 13% | 14% | 16% | 11% | 10% | 15% | 11% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 940 | 920 | 1,055 | 1,123 | 1,183 | 1,262 | 1,344 | 1,411 | 1,539 | 1,676 | 1,766 | 1,901 |
| Borrowings | 1,221 | 1,534 | 1,038 | 508 | 769 | 996 | 872 | 961 | 581 | 486 | 150 | 9 |
| Other Liabilities | 232 | 355 | 297 | 143 | 237 | 164 | 163 | 184 | 226 | 260 | 297 | 235 |
| Total Liabilities | 2,405 | 2,821 | 2,402 | 1,786 | 2,202 | 2,434 | 2,390 | 2,569 | 2,359 | 2,435 | 2,226 | 2,157 |
| Fixed Assets | 917 | 1,138 | 1,103 | 1,082 | 1,026 | 1,004 | 954 | 1,049 | 1,078 | 1,071 | 1,189 | 1,145 |
| CWIP | 22 | 15 | 34 | 4 | 24 | 90 | 145 | 61 | 22 | 112 | 11 | 106 |
| Investments | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 263 |
| Other Assets | 1,466 | 1,667 | 1,263 | 699 | 1,151 | 1,340 | 1,291 | 1,458 | 1,257 | 1,249 | 1,022 | 643 |
| Total Assets | 2,405 | 2,821 | 2,402 | 1,786 | 2,202 | 2,434 | 2,390 | 2,569 | 2,359 | 2,435 | 2,226 | 2,157 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 20 | 178 | 645 | 588 | -192 | -57 | 236 | 33 | 502 | 274 | 430 | 514 |
| Investing | -74 | -275 | -52 | -16 | -27 | -106 | -61 | -75 | -57 | -130 | -65 | -342 |
| Financing | 61 | 107 | -604 | -579 | 219 | 167 | -179 | 42 | -443 | -144 | -369 | -161 |
| Net Cash Flow | 7 | 10 | -11 | -6 | 0 | 4 | -5 | 0 | 3 | 1 | -5 | 12 |
| Free Cash Flow | -68 | -98 | 591 | 570 | -222 | -164 | 173 | -45 | 438 | 135 | 355 | 405 |
| CFO/OP | 16 | 85 | 198 | 289 | -96 | -16 | 120 | 26 | 180 | 104 | 218 | 279 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16 | 33 | 24 | 17 | 42 | 43 | 38 | 63 | 20 | 22 | 14 | 6 |
| Inventory Days | 757 | 485 | 296 | 188 | 529 | 330 | 339 | 255 | 205 | 247 | 277 | 142 |
| Days Payable | 39 | 50 | 27 | 28 | 95 | 21 | 20 | 22 | 17 | 19 | 27 | 9 |
| Cash Conversion Cycle | 734 | 468 | 293 | 176 | 476 | 352 | 356 | 296 | 209 | 249 | 263 | 138 |
| Working Capital Days | 109 | 98 | 68 | 71 | 115 | 91 | 96 | 81 | 85 | 101 | 142 | 94 |
| ROCE % | 4% | 6% | 12% | 8% | 7% | 8% | 7% | 7% | 12% | 12% | 9% | 9% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bannari Amman Sugars insights
60 extracted metrics + investor summaries across FY11–FY26.
Documents
Frequently Asked Questions about Bannari Amman Sugars
What does Bannari Amman Sugars Ltd do?
Where is Bannari Amman Sugars Ltd (BANARISUG) listed?
Which sector does Bannari Amman Sugars Ltd belong to?
What is the market capitalisation of Bannari Amman Sugars Ltd?
What is the PE ratio of Bannari Amman Sugars Ltd?
What is the 52-week high and low of Bannari Amman Sugars Ltd?
Does Bannari Amman Sugars Ltd pay dividends?
What is the Return on Equity (ROE) of Bannari Amman Sugars Ltd?
Company Information
Bannari Amman Sugars is an integrated South Indian sugar and bio-energy producer operating five sugar mills in Tamil Nadu and Karnataka, with bagasse cogeneration, two molasses-based distilleries, seven windmills, agri-natural fertiliser/biocompost and a scaled-down granite operation. Capacity comprises 23,700 TCD sugarcane crushing, 217.5 KLPD distillery, 129.8 MW cogeneration and 8.75 MW wind power. [1][2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BANARISUG.md for Bannari Amman Sugars Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.